Anti-hormonal maintenance treatment with the CDK4/6 inhibitor ribociclib after 1st line chemotherapy in hormone receptor positive / HER2 negative metastatic breast cancer: A phase II trial (AMICA)
-
Published:2023-12
Issue:
Volume:72
Page:103575
-
ISSN:0960-9776
-
Container-title:The Breast
-
language:en
-
Short-container-title:The Breast
Author:
Decker Thomas,
Lüdtke-Heckenkamp Kerstin,
Melnichuk Luidmila,
Hirmas NaderORCID,
Lübbe Kristina,
Zahn Mark-Oliver,
Schmidt MarcusORCID,
Denkert Carsten,
Lorenz Ralf,
Müller Volkmar,
Zahm Dirk-Michael,
Mundhenke Christoph,
Bauer Stefan,
Thill MarcORCID,
Seropian Peter,
Filmann Natalie,
Loibl Sibylle
Funder
Novartis Pharma AG
Novartis
Subject
General Medicine,Surgery
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献